Noah S. Kornblum
Experienced in Glossitis

Dr. Noah S. Kornblum

Oncology
Montefiore Einstein
Montefiore Medical Park At Eastchester
1695 Eastchester Road, 
Bronx, NY 
27 Years of Experience
Experienced in Glossitis
Montefiore Einstein
Montefiore Medical Park At Eastchester
1695 Eastchester Road, 
Bronx, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Noah Kornblum is an Oncologist in Bronx, New York. Dr. Kornblum has been practicing medicine for over 27 years and is rated as an Experienced provider by MediFind in the treatment of Glossitis. His top areas of expertise are Adult T-Cell Leukemia, Multiple Myeloma, Large-Cell Immunoblastic Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Sackler School Of Medicine, New York
Residency
University of California Los Angeles Medical
Specialties
Oncology
Licenses
Internal Medicine in NY
Fellowships
Montefiore Medical Center
Hospital Affiliations
Montefiore Medical Center
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Archcare
  • MEDICARE SNP
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Hamaspik
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Nippon Life
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Senior Whole Health
  • MEDICARE-MEDICAID PLAN
The Wellness Plan Medical Centers
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Montefiore Medical Park at Eastchester
1695 Eastchester Road, Bronx, NY 10461
Call: 718-405-8505

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase I Study of MLN8237 in Combination With Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma
A Phase I Study of MLN8237 in Combination With Bortezomib and Rituximab in Relapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Biological, Drug, Other
Study Drugs: Alisertib, Bortezomib, Rituximab
Study Phase: Phase 1
A Phase I Trial of MEDI-570 in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)
A Phase I Trial of MEDI-570 in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)
Enrollment Status: Active_not_recruiting
Publish Date: June 29, 2025
Intervention Type: Other, Biological
Study Drug: MEDI-570
Study Phase: Phase 1
A Phase I/II, Open-label, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-Drug Conjugate GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed / Refractory Multiple Myeloma - DREAMM-6
A Phase I/II, Open-label, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-Drug Conjugate GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed / Refractory Multiple Myeloma - DREAMM-6
Enrollment Status: Completed
Publish Date: March 18, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Lenalidomide, Dexamethasone, Bortezomib
Study Phase: Phase 1/Phase 2
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

51 Total Publications

CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.
Journal: JCO precision oncology
Published: July 25, 2025
View All 51 Publications
Similar Doctors
Distinguished in Glossitis
Dr. Mikhail G. Grinberg
Hematology Oncology | Hematology | Oncology
Distinguished in Glossitis
Dr. Mikhail G. Grinberg
Hematology Oncology | Hematology | Oncology

Hematology Oncology Associates Of Brooklyn, Llp

1660 E 14th St, Suite 401, 
Brooklyn, NY 
 (19.2 miles away)
718-382-8500
Languages Spoken:
English
See accepted insurances

Mikhail Grinberg is a Hematologist Oncology specialist and a Hematologist in Brooklyn, New York. Dr. Grinberg is rated as a Distinguished provider by MediFind in the treatment of Glossitis. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Glossitis, and Pernicious Anemia.

Distinguished in Glossitis
Dr. Joseph Lebowicz
Hematology Oncology | Hematology | Oncology
Distinguished in Glossitis
Dr. Joseph Lebowicz
Hematology Oncology | Hematology | Oncology

Hematology Oncology Associates Of Brooklyn, Llp

1660 E 14th St, Suite 401, 
Brooklyn, NY 
 (19.2 miles away)
718-382-8500
Languages Spoken:
English
See accepted insurances

Joseph Lebowicz is a Hematologist Oncology specialist and a Hematologist in Brooklyn, New York. Dr. Lebowicz is rated as a Distinguished provider by MediFind in the treatment of Glossitis. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Glossitis, and Pernicious Anemia.

Advanced in Glossitis
Dr. Inna Sominsky
Hematology Oncology | Hematology | Oncology
Advanced in Glossitis
Dr. Inna Sominsky
Hematology Oncology | Hematology | Oncology

Hematology Oncology Associates Of Brooklyn, Llp

1660 E 14th St, Suite 401, 
Brooklyn, NY 
 (19.2 miles away)
718-382-8500
Languages Spoken:
English
See accepted insurances

Inna Sominsky is a Hematologist Oncology specialist and a Hematologist in Brooklyn, New York. Dr. Sominsky is rated as a Distinguished provider by MediFind in the treatment of Glossitis. Her top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Vitamin B12 Deficiency, and Subacute Combined Degeneration.

VIEW MORE GLOSSITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kornblum's expertise for a condition
ConditionClose
    • Distinguished
    • Adult T-Cell Leukemia
      Dr. Kornblum is
      Distinguished
      . Learn about Adult T-Cell Leukemia.
      See more Adult T-Cell Leukemia experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Kornblum is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Large-Cell Immunoblastic Lymphoma
      Dr. Kornblum is
      Distinguished
      . Learn about Large-Cell Immunoblastic Lymphoma.
      See more Large-Cell Immunoblastic Lymphoma experts
    • Multiple Myeloma
      Dr. Kornblum is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Myelodysplastic Syndrome (MDS)
      Dr. Kornblum is
      Distinguished
      . Learn about Myelodysplastic Syndrome (MDS).
      See more Myelodysplastic Syndrome (MDS) experts
    • Non-Hodgkin Lymphoma
      Dr. Kornblum is
      Distinguished
      . Learn about Non-Hodgkin Lymphoma.
      See more Non-Hodgkin Lymphoma experts
    • Advanced
    • Acute Myeloid Leukemia (AML)
      Dr. Kornblum is
      Advanced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • B-Cell Lymphoma
      Dr. Kornblum is
      Advanced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    • Bone Marrow Transplant
      Dr. Kornblum is
      Advanced
      . Learn about Bone Marrow Transplant.
      See more Bone Marrow Transplant experts
    • Chronic B-Cell Leukemia (CBCL)
      Dr. Kornblum is
      Advanced
      . Learn about Chronic B-Cell Leukemia (CBCL).
      See more Chronic B-Cell Leukemia (CBCL) experts
    • Chronic T-Cell Leukemia (CTCL)
      Dr. Kornblum is
      Advanced
      . Learn about Chronic T-Cell Leukemia (CTCL).
      See more Chronic T-Cell Leukemia (CTCL) experts
    • Diffuse Large B-Cell Lymphoma (DLBCL)
      Dr. Kornblum is
      Advanced
      . Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
      See more Diffuse Large B-Cell Lymphoma (DLBCL) experts
    View All 16 Advanced Conditions
    • Experienced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Kornblum is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Kornblum is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Kornblum is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Agranulocytosis
      Dr. Kornblum is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Kornblum is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Angioimmunoblastic T-cell Lymphoma
      Dr. Kornblum is
      Experienced
      . Learn about Angioimmunoblastic T-cell Lymphoma.
      See more Angioimmunoblastic T-cell Lymphoma experts
    View All 60 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.